Unlock instant, AI-driven research and patent intelligence for your innovation.

Influenza virus backbone

An influenza virus, amino acid technology, applied in the direction of viruses, viral peptides, antiviral agents, etc., can solve the problems of low efficiency and poor yield of vaccines

Pending Publication Date: 2022-02-18
FLUGEN
View PDF5 Cites 0 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Problems solved by technology

However, vaccine production in cell culture often results in poor yields
In addition, MDCK cells are generally more permeable than Vero cells, making vaccine production in Vero cells relatively inefficient

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Image

Smart Image Click on the blue labels to locate them in the text.
Viewing Examples
Smart Image
  • Influenza virus backbone
  • Influenza virus backbone
  • Influenza virus backbone

Examples

Experimental program
Comparison scheme
Effect test

Embodiment approach

[0110] The invention provides the following embodiments:

[0111] (1) Influenza virus comprising PB1, PB2, PA, NP and NS gene segments, wherein: (a) the PB1 gene segment encodes a PB1 protein having an amino acid sequence comprising selected amino acids, wherein the selected The amino acid comprises leucine at position 40 and tryptophan at position 180, and at least one of asparagine at position 464 or serine at position 607, and wherein the PB1 gene segment optionally comprising a cytosine to uracil promoter mutation at nucleotide position 4; (b) the PB2 gene segment encodes a PB2 protein having an amino acid sequence comprising a selected amino acid, wherein the selected amino acid comprising valine at position 504 and optionally isoleucine at position 467 and valine at position 529, and wherein the PB2 gene segment optionally comprises at nucleotide position 4 (c) said PA gene segment encodes a PA protein having an amino acid sequence comprising a selected amino acid compr...

Embodiment 1

[0154] This example compares the growth of viruses with different backbones in Vero cells.

[0155] The high-yield PR8 ("PR8-HY") backbone described in Ping et al., Nature Communications, 6:8148 (2015) (which comprises ) of the mutated backbone gene segment) was used to extract from two different influenza viruses representing two influenza A virus subtypes in seasonal vaccines, namely A / Massachusetts / 15 / 2013 (MA15; H1N1) and A / Brisbane / 10 / 2007 (Bris10, H3N2) Generation of M2SR virus encoding HA and NA.

[0156] Specifically, cDNAs encoding the HA and NA gene segments from these viruses were transfected together with cDNAs encoding the PR8-HY backbone gene segment and the M2SR M gene segment (SEQ ID NO: 11). As described in Example 8, HA derived from MA15 was Vero adapted (MA15V). The two viruses produced were HY-M2SR-MA15V and Bris10 M2SR-HY. Viruses were generated by standard virus rescue techniques and expanded in MDCK cells stably expressing M2 (ie, M2CK cells), as des...

Embodiment 2

[0166] This example shows the production of viruses capable of enhanced growth in Vero cells. To generate these viruses, two M2SR viruses containing NA and Vero-adapted HA derived from A / Massachusetts / 15 / 2013 (i.e. MA15VM2SR virus) or derived from A / California / 07 / 2009 were serially passaged in M2VeroA cells (ie, CA07 M2SR virus) and contain the PR8-HY backbone (ie, HY-M2SR-MA15V and HY-M2SR-CA07).

[0167] Viruses were serially diluted 10-fold and adsorbed onto M2VeroA cells in TC-6 plates using standard influenza virus techniques. However, prior to virus infection, the cell culture medium was removed and the cells were washed with PBS. After adsorption for 60 min at 35°C, virus growth medium containing trypsin / TPCK was added. Cultures were incubated at 35°C for 4-7 days. Culture supernatants were harvested from the highest dilution well showing cytopathic effect and HA activity. Cytopathic effect (CPE) was determined by visual inspection of the monolayer under low power o...

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

PUM

No PUM Login to View More

Abstract

The invention provides an influenza virus that demonstrates enhanced growth in Vero cells. The influenza virus includes PB1, PB2, PA, NP, and NS gene segments encoding proteins having amino acid sequences with selected amino acids. Optionally, at least one of the PB1, PB2, and PA gene segments includes a cytosine to uracil promoter mutation at nucleotide position 4. The invention also provides a pharmaceutical formulation containing the influenza virus, as well as a method of eliciting an immune response in a mammal by administering the influenza virus to the mammal, and a method for generating the influenza virus.

Description

[0001] Cross References to Related Applications [0002] This patent application claims the benefit of U.S. Provisional Patent Application 62 / 858,737, filed June 7, 2019, which is hereby incorporated by reference in its entirety. [0003] Materials submitted electronically are incorporated by reference [0004] Incorporated herein by reference in its entirety is the computer-readable nucleotide / amino acid sequence listing filed concurrently with this document and identified as follows: entitled "749488SequenceListing_ST25.txt", created on June 2, 2020 as a copy of 73,600 byte ASCII (text) file. [0005] Background of the invention [0006] Influenza, or "flu," is a highly contagious viral infection that kills thousands of people worldwide each year. Based on the core protein classification of influenza viruses, there are four types of influenza viruses (ie, A, B, C, and D), although seasonal epidemics are most often caused by circulating influenza A and B viruses. [0007] A...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

Application Information

Patent Timeline
no application Login to View More
Patent Type & Authority Applications(China)
IPC IPC(8): A61K39/145C07K14/11
CPCC07K14/005C12N2760/16122C12N2760/16151C12N2760/16152C12N2760/16134C12N7/00A61K39/12A61K2039/5254A61K2039/543A61K2039/545A61K2039/70A61K2039/58A61K39/145A61P31/16
Inventor 八田宁子迈克尔·J·莫瑟帕慕克·比尔塞尔
Owner FLUGEN